Quanterix (QTRX) to Release Earnings on Monday

Quanterix (NASDAQ:QTRX) is expected to be posting its Q4 2025 results after the market closes on Monday, March 2nd. Analysts expect Quanterix to post earnings of ($0.27) per share and revenue of $37.9520 million for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Monday, March 2, 2026 at 4:30 PM ET.

Quanterix Trading Down 2.5%

Shares of QTRX opened at $6.55 on Friday. Quanterix has a twelve month low of $4.05 and a twelve month high of $8.77. The firm has a market capitalization of $305.95 million, a P/E ratio of -2.81 and a beta of 1.09. The stock’s fifty day simple moving average is $6.52 and its 200 day simple moving average is $5.97.

Wall Street Analyst Weigh In

QTRX has been the topic of a number of research reports. Canaccord Genuity Group raised their price objective on Quanterix from $5.00 to $8.00 and gave the stock a “hold” rating in a report on Monday, December 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of Quanterix in a research report on Thursday, January 22nd. Finally, Wall Street Zen upgraded shares of Quanterix from a “sell” rating to a “hold” rating in a report on Monday, December 29th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Quanterix currently has a consensus rating of “Hold” and a consensus price target of $11.33.

Hedge Funds Weigh In On Quanterix

A number of institutional investors and hedge funds have recently bought and sold shares of QTRX. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Quanterix during the fourth quarter valued at approximately $27,000. Quarry LP increased its stake in Quanterix by 277,300.0% during the 3rd quarter. Quarry LP now owns 5,548 shares of the company’s stock worth $30,000 after buying an additional 5,546 shares during the period. Renaissance Technologies LLC acquired a new position in Quanterix in the 4th quarter worth $75,000. HUB Investment Partners LLC purchased a new position in Quanterix in the 2nd quarter valued at about $81,000. Finally, HRT Financial LP purchased a new position in Quanterix in the 4th quarter valued at about $82,000. Hedge funds and other institutional investors own 86.48% of the company’s stock.

About Quanterix

Quanterix Corporation is a life sciences and diagnostics company specializing in ultra-sensitive digital immunoassay platforms. Its proprietary Single Molecule Array (Simoa) technology enables researchers to detect and quantify proteins, peptides and nucleic acids at femtomolar concentrations, offering sensitivity that surpasses traditional immunoassay methods. By translating single-molecule detection into routine laboratory workflows, Quanterix aims to accelerate biomarker discovery and the development of novel diagnostics and therapeutics.

The company’s core product portfolio includes the Simoa HD-1 and HD-X Analyzers, which automate high-throughput digital immunoassays for quantifying low-abundance biomarkers.